NOVT · Novanta Inc

The sales reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan that was adopted on September 11, 2025 through a trust for which the reporting person's spouse is a trustee.

The sales reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan that was adopted on September 11, 2025 through a trust for which the reporting person's spouse is a trustee.

This transaction was executed in multiple trades ranging from $161.83 to $162.76. The price reported above reflects the weighted-average price. The reporting person hereby undertakes to provide upon request from the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

The sales reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan that was adopted on September 11, 2025 through a trust for which the reporting person's spouse is a trustee.

This transaction was executed in multiple trades ranging from $160.74 to $161.74. The price reported above reflects the weighted-average price. The reporting person hereby undertakes to provide upon request from the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

The sales reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan that was adopted on September 11, 2025 through a trust for which the reporting person's spouse is a trustee.

This transaction was executed in multiple trades ranging from $163.09 to $163.95. The price reported above reflects the weighted-average price. The reporting person hereby undertakes to provide upon request from the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

The sales reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan that was adopted on September 11, 2025 through a trust for which the reporting person's spouse is a trustee.

This transaction was executed in multiple trades ranging from $159.72 to $160.66. The price reported above reflects the weighted-average price. The reporting person hereby undertakes to provide upon request from the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

The sales reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan that was adopted on September 11, 2025 through a trust for which the reporting person's spouse is a trustee.

The sales reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan that was adopted on September 11, 2025 through a trust for which the reporting person's spouse is a trustee.

This transaction was executed in multiple trades ranging from $165.87 to $166.41. The price reported above reflects the weighted-average price. The reporting person hereby undertakes to provide upon request from the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

The sales reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan that was adopted on September 11, 2025 through a trust for which the reporting person's spouse is a trustee.

This transaction was executed in multiple trades ranging from $170.78 to $171.70. The price reported above reflects the weighted-average price. The reporting person hereby undertakes to provide upon request from the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

The sales reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan that was adopted on September 11, 2025 through a trust for which the reporting person's spouse is a trustee.

This transaction was executed in multiple trades ranging from $167.11 to $168.05. The price reported above reflects the weighted-average price. The reporting person hereby undertakes to provide upon request from the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

The sales reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan that was adopted on September 11, 2025 through a trust for which the reporting person's spouse is a trustee.

This transaction was executed in multiple trades ranging from $169.39 to $170.11. The price reported above reflects the weighted-average price. The reporting person hereby undertakes to provide upon request from the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

The sales reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan that was adopted on September 11, 2025 through a trust for which the reporting person's spouse is a trustee.

This transaction was executed in multiple trades ranging from $168.30 to $169.30. The price reported above reflects the weighted-average price. The reporting person hereby undertakes to provide upon request from the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

The sales reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan that was adopted on September 11, 2025 through a trust for which the reporting person's spouse is a trustee.

The sales reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan that was adopted on September 11, 2025 through a trust for which the reporting person's spouse is a trustee.

This transaction was executed in multiple trades ranging from $151.06 to $151.51. The price reported above reflects the weighted-average price. The reporting person hereby undertakes to provide upon request from the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

The sales reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan that was adopted on September 11, 2025 through a trust for which the reporting person's spouse is a trustee.

This transaction was executed in multiple trades ranging from $131.24 to $132.24. The price reported above reflects the weighted-average price. The reporting person hereby undertakes to provide upon request from the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

The sales reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan that was adopted on September 11, 2025 through a trust for which the reporting person's spouse is a trustee.

This transaction was executed in multiple trades ranging from $133.27 to $133.30. The price reported above reflects the weighted-average price. The reporting person hereby undertakes to provide upon request from the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

The sales reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan that was adopted on September 11, 2025 through a trust for which the reporting person's spouse is a trustee.

This transaction was executed in multiple trades ranging from $130.21 to $131.16. The price reported above reflects the weighted-average price. The reporting person hereby undertakes to provide upon request from the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

The sales reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan that was adopted on September 11, 2025 through a trust for which the reporting person's spouse is a trustee.

This transaction was executed in multiple trades ranging from $132.25 to $133.08. The price reported above reflects the weighted-average price. The reporting person hereby undertakes to provide upon request from the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

The sales reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan that was adopted on September 11, 2025 through a trust for which the reporting person's spouse is a trustee.

This transaction was executed in multiple trades ranging from $130.00 to $130.28. The price reported above reflects the weighted-average price. The reporting person hereby undertakes to provide upon request from the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

The sales reported in this Form 4 was effected pursuant to a pre-established Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2025.

This transaction was executed in multiple trades ranging from $115.40 to $116.40. The price reported above reflects the weighted-average price. The reporting person hereby undertakes to provide upon request from the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

The sales reported in this Form 4 was effected pursuant to a pre-established Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2025.

The sales reported in this Form 4 was effected pursuant to a pre-established Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2025.

This transaction was executed in multiple trades ranging from $118.53 to $119.02. The price reported above reflects the weighted-average price. The reporting person hereby undertakes to provide upon request from the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

The sales reported in this Form 4 was effected pursuant to a pre-established Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2025.

The Stock Options vested in three equal installments on March 30, 2017, March 30, 2018, and March 30, 2019.

The sales reported in this Form 4 was effected pursuant to a pre-established Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2025.

This transaction was executed in multiple trades ranging from $116.41 to $117.40. The price reported above reflects the weighted-average price. The reporting person hereby undertakes to provide upon request from the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

The sales reported in this Form 4 was effected pursuant to a pre-established Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2025.

This transaction was executed in multiple trades ranging from $117.42 to $118.41. The price reported above reflects the weighted-average price. The reporting person hereby undertakes to provide upon request from the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

The sales reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan that was adopted on September 11, 2025 through a trust for which the reporting person's spouse is a trustee.

This transaction was executed in multiple trades ranging from $135.86 to $136.86. The price reported above reflects the weighted-average price. The reporting person hereby undertakes to provide upon request from the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

The sales reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan that was adopted on September 11, 2025 through a trust for which the reporting person's spouse is a trustee.

This transaction was executed in multiple trades ranging from $140.08 to $140.75. The price reported above reflects the weighted-average price. The reporting person hereby undertakes to provide upon request from the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

The sales reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan that was adopted on September 11, 2025 through a trust for which the reporting person's spouse is a trustee.

This transaction was executed in multiple trades ranging from $137.90 to $138.84. The price reported above reflects the weighted-average price. The reporting person hereby undertakes to provide upon request from the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

The sales reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan that was adopted on September 11, 2025 through a trust for which the reporting person's spouse is a trustee.

This transaction was executed in multiple trades ranging from $134.52 to $134.98. The price reported above reflects the weighted-average price. The reporting person hereby undertakes to provide upon request from the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

The sales reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan that was adopted on September 11, 2025 through a trust for which the reporting person's spouse is a trustee.

This transaction was executed in multiple trades ranging from $138.96 to $139.96. The price reported above reflects the weighted-average price. The reporting person hereby undertakes to provide upon request from the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

The sales reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan that was adopted on September 11, 2025 through a trust for which the reporting person's spouse is a trustee.

This transaction was executed in multiple trades ranging from $133.03 to $133.96. The price reported above reflects the weighted-average price. The reporting person hereby undertakes to provide upon request from the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

The sales reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan that was adopted on September 11, 2025 through a trust for which the reporting person's spouse is a trustee.

The sales reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan that was adopted on September 11, 2025 through a trust for which the reporting person's spouse is a trustee.

This transaction was executed in multiple trades ranging from $136.89 to $137.79. The price reported above reflects the weighted-average price. The reporting person hereby undertakes to provide upon request from the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Each Restricted Stock Unit represents the right to receive one Novanta Inc. common share upon vesting of such Restricted Stock Unit.

On February 24, 2023, the reporting person was granted restricted stock units, vesting in three equal installments beginning on the first anniversary of the grant date.

Each Restricted Stock Unit represents the right to receive one Novanta Inc. common share upon vesting of such Restricted Stock Unit.

Each Restricted Stock Unit represents the right to receive one Novanta Inc. common share upon vesting of such Restricted Stock Unit.

Each Restricted Stock Unit represents the right to receive one Novanta Inc. common share upon vesting of such Restricted Stock Unit.

On February 24, 2023, the reporting person was granted restricted stock units, vesting in three equal installments beginning on the first anniversary of the grant date.

Each Performance Stock Unit represents the right to receive one Novanta Inc. common share upon vesting of such Performance Stock Unit.

The number of shares underlying Performance Stock Unit award originally granted on February 24, 2021 became fixed upon ratification by the Compensation Committee of the Board of Directors based on 100% achievement of performance target, vesting as follows: 5,425 shares vested on February 24, 2025 and 5,426 shares vested on February 24, 2026.

Each Performance Stock Unit represents the right to receive one Novanta Inc. common share upon vesting of such Performance Stock Unit.

The number of shares underlying Performance Stock Unit award originally granted on February 24, 2021 became fixed upon ratification by the Compensation Committee of the Board of Directors based on 100% achievement of performance target, vesting as follows: 10,851 vested on February 24, 2025 and 10,852 vested on February 24, 2026.

Each Performance Stock Unit represents the right to receive one Novanta Inc. common share upon vesting of such Performance Stock Unit.

Each Performance Stock Unit represents the right to receive one Novanta Inc. common share upon vesting of such Performance Stock Unit.

Each Restricted Stock Unit represents the right to receive one Novanta Inc. common share upon vesting of such Restricted Stock Unit.

The Restricted Stock Units vest in three equal installments on February 21, 2025, February 23, 2026 and February 22, 2027.

Each Restricted Stock Unit represents the right to receive one Novanta Inc. common share upon vesting of such Restricted Stock Unit.

Each Restricted Stock Unit represents the right to receive one Novanta Inc. common share upon vesting of such Restricted Stock Unit.

Each Restricted Stock Unit represents the right to receive one Novanta Inc. common share upon vesting of such Restricted Stock Unit.

The Restricted Stock Units vest in three equal installments on February 21, 2025, February 23, 2026 and February 22, 2027.